Top Institutions in Ophthalmology and Retinal Disease Research
Leading institutions employ large patient datasets, molecular and cellular biology techniques, and clinical trials to investigate iron metabolism's impact on retinal degeneration and develop targeted therapies such as gene and protein-based treatments.
-
#100
Inserm (French National Institute of Health and Medical Research)
Paris, Île-de-France
Inserm is a leading European biomedical research institution with strong expertise in retinal diseases and iron metabolism, collaborating extensively on translational research and clinical trials in AMD.
-
#92
Massachusetts Eye and Ear Infirmary, Harvard Medical School
Boston, MA
A top US center for retinal disease research and clinical trials, with extensive work on AMD pathophysiology and novel therapeutic development including gene and protein therapies targeting retinal degeneration.
-
#88
Bascom Palmer Eye Institute, University of Miami
Miami, FL
Recognized internationally for clinical and translational research in AMD, including studies on iron metabolism and oxidative stress pathways contributing to retinal degeneration.
-
#85
Johns Hopkins Wilmer Eye Institute
Baltimore, MD
Wilmer Eye Institute is a leader in retinal disease research with a focus on molecular mechanisms of AMD and innovative therapeutic approaches including gene therapy and iron regulation.
-
#80
Cochin Hospital
Paris, Île-de-France
Cochin Hospital collaborates closely with Inserm and industry partners on clinical and translational research in AMD, contributing significant patient data and expertise in retinal disease progression.